Carriage of GB virus C hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons

被引:118
作者
Lefrère, JJ
Roudot-Thoraval, F
Morand-Joubert, L
Petit, JC
Lerable, J
Thauvin, M
Mariotti, M
机构
[1] Inst Natl Transfus Sanguine, F-75012 Paris, France
[2] Hop St Antoine, Virol Lab, F-75571 Paris, France
[3] Hop Henri Mondor, Serv Sante Publ, F-94010 Creteil, France
关键词
D O I
10.1086/314671
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The prevalence of GB virus C (GBV-C) infection is high in human immunodeficiency virus (HIV)-infected persons. However, the long-term consequences of coinfection are unknown. HIV-positive persons with a well-defined duration of infection were screened on the basis of their GBV-C/hepatitis G virus (HGV) RNA status and studied. GBV-C/HGV viremia was observed in 23, who carried the virus over a mean of 7.7 years. All parameters (survival, CDC stage B/C, HIV RNA load, CD4 T cell count) showed significant differences in terms of the cumulative progression rate between persons positive and negative for GBV-C/HGV RNA. When GBV-C/HGV RNA-positive and -unexposed subjects were matched by age, sex, baseline HIV RNA load, and baseline CD4 T cell count, HIV disease progression appeared worse in GBV-C/HGV RNA-negative subjects. The carriage of GBV-C/HGV RNA is associated with a slower progression of HIV disease in coinfected persons.
引用
收藏
页码:783 / 789
页数:7
相关论文
共 30 条
[1]   The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease [J].
Alter, HJ ;
Nakatsuji, Y ;
Melpolder, J ;
Wages, J ;
Wesley, R ;
Shih, JWK ;
Kim, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (11) :747-754
[2]   The cloning and clinical implications of HGV and HGBV-C [J].
Alter, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (23) :1536-1537
[3]   GEMHEP multicenter quality control study of PCR detection of GB virus C hepatitis G virus RNA in serum [J].
Bogard, M ;
BuffetJanvresse, C ;
Cantaloube, JF ;
Biagini, P ;
Duverlie, G ;
Castelain, S ;
Izopet, J ;
Dubois, M ;
Defer, C ;
Lepot, I ;
Coste, J ;
Marcellin, P ;
MartinotPeignoux, M ;
Halfon, P ;
Gerolami, V ;
Franguel, L ;
Pawlotsky, JM ;
RoudotThoraval, F ;
Dussaix, E ;
Loiseau, P ;
Ravera, N ;
Lewin, P ;
Lamoril, J ;
Lerable, J ;
Bouchardeau, F ;
Laperche, S ;
Mariotti, M ;
Lefrere, JJ ;
Nicot, T ;
Denis, F ;
Gassain, M ;
Merel, P ;
Trepo, C ;
Thiers, V ;
Brechot, C ;
Ferec, C ;
Mercier, B ;
StollKeller, F ;
Palmer, P ;
Lebon, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (12) :3298-3300
[4]   VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
CAO, YZ ;
QIN, LM ;
ZHANG, LQ ;
SAFRIT, J ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :201-208
[5]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[6]   An ELISA for detection of antibodies to the E2 protein of GB virus C [J].
Dille, BJ ;
Surowy, TK ;
Gutierrez, RA ;
Coleman, PF ;
Knigge, MF ;
Carrick, RJ ;
Aach, RD ;
Hollinger, FB ;
Stevens, CE ;
Barbosa, LH ;
Nemo, GJ ;
Mosley, JW ;
Dawson, GJ ;
Mushahwar, IK .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (02) :458-461
[7]  
Dixon W. J., 1990, BMDP STAT SOFTWARE
[8]   GB virus C hepatitis G virus infection: A favorable prognostic factor in human immunodeficiency virus-infected patients? [J].
Heringlake, S ;
Ockenga, J ;
Tillmann, HL ;
Trautwein, C ;
Meissner, D ;
Stoll, M ;
Hunt, J ;
Jou, C ;
Solomon, N ;
Schmidt, RE ;
Manns, MP .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (06) :1723-1726
[9]   NASBA ISOTHERMAL ENZYMATIC INVITRO NUCLEIC-ACID AMPLIFICATION OPTIMIZED FOR THE DIAGNOSIS OF HIV-1 INFECTION [J].
KIEVITS, T ;
VANGEMEN, B ;
VANSTRIJP, D ;
SCHUKKINK, R ;
DIRCKS, M ;
ADRIAANSE, H ;
MALEK, L ;
SOOKNANAN, R ;
LENS, P .
JOURNAL OF VIROLOGICAL METHODS, 1991, 35 (03) :273-286
[10]   Hepatitis G virus in immunosuppressed paediatric allograft recipients [J].
Kudo, T ;
Morishima, T ;
Tsuzuki, K ;
Orito, E ;
Mizokami, M .
LANCET, 1996, 348 (9029) :751-751